MEXA  โ€ข  NASDAQ  โ€ข  SLN US equities ยท completed weekly research
MEXA
๐Ÿ‡บ๐Ÿ‡ธ NASDAQ ยท Healthcare ยท Biotechnology

SLN beta and relative strength

Silence Therapeutics PLC

SLN is strengthening above benchmark with market-like sensitivity to QQQ.

Week ending Latest completed weekly edition
Next update 15:40 UK ยท after Stage Analysis
One-year beta 1.01Market-like sensitivity ยท Falling
Movement explained 4%20% weekly correlation
Relative strength+73.77Strengthening above benchmark
Downside beta -2.22Upside beta 2.26
One-year excess return+122.8%148.0% stock ยท 25.2% benchmark
Directional participation

SLN in rising and falling QQQ weeks

These percentages count what actually happened in completed weeks. They describe historical participation, not certainty about the next move.

Latest 52-week reading Directional participation is mixed

The stock sometimes follows the benchmark, but neither direction has been consistently dependable.

65% of directional weeks moved the same way.
When QQQ rose66%

SLN also rose in 66% of 29 rising benchmark weeks.

When QQQ fell61%

SLN also fell in 61% of 23 falling benchmark weeks.

Market state now Range-bound market with active movement
-0.5% over 13 weeks21.8% volatility

After 16 earlier matches by direction and movement level, often separates from the benchmark.

Joined rising weeks42%
Joined falling weeks25%
Limited sample ยท 40% same-direction rate ยท 0.18 beta
Benchmark fit

SLN sensitivity to QQQ

The benchmark relationship is weak and explains 4% of weekly movement over the latest year. Current beta is 1.01 and is falling.

Likely beta range-0.39 to 2.41

A wider range means the beta estimate is less precise.

Beta stability36/100

How consistently rolling beta has held its level and direction.

Annualised alpha+108.5%

The weekly regression intercept annualised; it is historical, not expected return.

Tracking error92.4%

Annualised volatility of returns above or below the benchmark.

Relationship directionRelationship weakening

-10.8 point change in movement explained across two distinct 26-week windows.

Beta and benchmark fitBeta is secondary evidence only
Weaker benchmark fitStronger benchmark fitLower sensitivityHigher sensitivity

The benchmark fit is too weak for the headline beta to be treated as a dependable description on its own.

Historical one-week sensitivity
If QQQ rises 1%+2.26%historically associated SLN move
If QQQ falls 1%+2.22%historically associated SLN move
Likely beta range -0.39 to 2.41 ยท width 2.80
Can the beta be trusted?Weak relationship
Movement explained4%
Stability36%
Directional agreement65%

Rolling beta

26-week estimates show whether market sensitivity is rising or falling.

Move across the chart to inspect a completed week.
Rolling betaMarket-like beta 1.00

Rolling relationship strength

Correlation shows direction; explained movement shows how useful the relationship has been.

Move across the chart to inspect a completed week.
CorrelationMovement explained
PeriodBetaCorrelationMovement explainedAlphaExcess returnTracking error
6 months0.5111%1%+229.8%+148.1%103.1%
1 year1.0120%4%+108.5%+122.8%92.4%
2 years0.8819%4%+16.0%-68.1%92.7%
3 years0.7818%3%+29.9%-55.1%84.6%
5 years0.7219%4%+10.3%-138.6%79.7%
Relative strength

SLN relative strength against QQQ

The score compares the stock/benchmark ratio with its trailing 52-week average. Above zero means the ratio is above trend; direction shows whether that advantage is building or fading.

Relative-strength trend

Current score 73.77 ยท 13-week change +86.32

Move across the chart to inspect a completed week.
Relative strengthZero baseline

Stock, benchmark and worthwhile peers

Each path starts at 100. Sector and industry appear only when their Market Structure indexes have enough constituents.

Move across the chart to inspect a completed week.
Sector ยท Healthcare+106.6 points

versus sector over 13 weeks ยท 948 constituents ยท 51% correlation

Industry ยท Biotechnology+109.2 points

versus industry over 13 weeks ยท 529 constituents ยท 51% correlation

Sensitivity to Healthcare2.34 beta

26% of weekly movement explained by the sector over one year.

Sensitivity to Biotechnology1.95 beta

26% of weekly movement explained by the industry over one year.

Return components

13-week and 52-week returns relative to QQQ

This is a return bridge, not a claim of cause. It starts with the benchmark return, then shows the difference added at sector, industry and ticker level.

Last 13 weeks+114.5 points vs benchmark
Broad market-0.5%
Sector difference+7.9%
Industry difference-2.5%
Ticker difference+109.2%

The largest source of relative strength was the ticker difference. SLN returned 114.0%; QQQ returned -0.5%.

Last 52 weeks+122.8 points vs benchmark
Broad market+25.2%
Sector difference-15.5%
Industry difference+8.1%
Ticker difference+130.3%

The largest source of relative strength was the ticker difference. SLN returned 148.0%; QQQ returned 25.2%.

Market conditions

SLN in rising and falling benchmark weeks

Upside beta is higher than downside beta, a historically favourable split.

Upside beta2.26209% upside capture
Downside beta-2.2215% downside capture
Current splitMore responsive in rising markets+4.48 beta gap
ConditionWeeksSLN averageQQQ averageBetaBeat benchmark
Benchmark up29+4.80%+2.29%2.2666%
Benchmark down23-0.28%-1.84%-2.2248%
Strongest benchmark weeks10+12.02%+4.05%0.0580%
Weakest benchmark weeks10+0.01%-3.12%-9.0940%
Quieter benchmark weeks26+0.42%+0.23%-1.8258%
Historical extremes

Strongest and weakest 13-week relative periods

Distinct 13-week windows prevent one long move from filling the list with overlapping dates.

Strongest relative periods

2023-11-03 to 2024-01-26+145.1 pts

SLN 168.1% ยท QQQ 23.0%

The return pattern shows that the industry added to the move, and the ticker moved beyond its peer backdrop.
2025-04-18 to 2025-07-11+128.5 pts

SLN 150.6% ยท QQQ 22.1%

The return pattern shows that the industry added to the move, and the ticker moved beyond its peer backdrop.
2026-05-22 to 2026-08-14+121.7 pts

SLN 124.9% ยท QQQ 3.2%

The return pattern shows that the sector moved the same way, and the ticker moved beyond its peer backdrop.

Weakest relative periods

2023-01-06 to 2023-03-31-80.1 pts

SLN -59.3% ยท QQQ 20.7%

The return pattern shows that the sector moved the same way, and the industry added to the move, and the ticker moved beyond its peer backdrop.
2024-09-20 to 2024-12-13-77.3 pts

SLN -65.5% ยท QQQ 11.8%

The return pattern shows that the sector moved the same way, and the industry added to the move, and the ticker moved beyond its peer backdrop.
2025-01-17 to 2025-04-11-46.8 pts

SLN -57.1% ยท QQQ -10.3%

The return pattern shows that the sector moved the same way, and the industry added to the move, and the ticker moved beyond its peer backdrop.
Pressure and timing

Drawdowns and lead/lag relationship

The strongest link is in the same week. Lead/lag evidence is treated as secondary because timing relationships can change quickly.

Drawdown from each rolling high

Worst available drawdown: SLN -90.0% ยท QQQ -35.1%

Move across the chart to inspect a completed week.
SLN drawdownQQQ drawdown
Ticker leads 2w
8%
Ticker leads 1w
-5%
Same week
18%
Benchmark leads 1w
15%
Benchmark leads 2w
4%
Observable signals

Signals that would confirm or change the reading

These are conditions to monitor, not price targets or forecasts.

Relative strengthAbove the zero baseline

A fall through zero would show that the stock/benchmark ratio has moved below its trailing one-year average.

Up/down beta+4.48 upside-minus-downside gap

Upside beta is higher than downside beta. The favourable split remains intact while that gap stays positive.

Exposure trendBeta is falling

Rising beta means broad-market moves are carrying more weight; falling beta means ticker-specific forces are carrying more weight.

Peer confirmation+109.2 points versus Biotechnology over 13 weeks

Strength shared by the peer group is broader; strength confined to the ticker is more company-specific and usually less stable.

Method and limits

Data and interpretation limits

Data
Completed weekly observations from 2020-09-18 to 2026-08-21 ยท 310 aligned weeks.
Current reading
52 weeks; rolling charts use 26 weeks.
Relative strength
Stock/benchmark ratio compared with its trailing 52-week average.
Peer evidence
At least 10 sector constituents and 5 industry constituents. Thin groups are excluded.
Boundary
Historical relationship analysis, not a forecast or a statement of cause. Historical relationships can break without warning.

Evidence context